Adverum Biotechnologies Inc reports results for the quarter ended in September - Earnings Summary

Adverum Biotechnologies

10/11/2022 22:08

* Adverum Biotechnologies Inc  ADVM.OQ  reported a quarterly
adjusted loss of 40 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 34 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Adverum Biotechnologies Inc's reported EPS for the quarter
was a
loss of 40 cents​.
    * The mean earnings estimate of analysts had risen by
about 0.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Adverum Biotechnologies Inc shares had fallen by 28.4%
this
quarter and lost 61.4% so far this year.
    * The company reported a quarterly loss of $40.13 million.
    * Wall Street's median 12-month price target for Adverum
Biotechnologies Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 10:07 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.34          -0.40          Missed
 Jun. 30 2022      -0.34          -0.44          Missed
 Mar. 31 2022      -0.31          -0.38          Missed
 Dec. 31 2021      -0.34          -0.35          Missed